Cardiol Therapeutics Reports Higher Q1 2026 Loss but Stronger Cash Position
at www.tipranks.com (Mon, 11-May 6:58 PM)
Cardiol Therapeutics’ Phase II MAvERIC Pericarditis Data Accepted by JAHA as Phase III Trial Nears Completion
at www.tipranks.com (Thu, 7-May 8:46 AM)
